Abstract

BackgroundChest CT is used for the assessment of the severity of patients infected with novel coronavirus 2019 (COVID-19). We collected chest CT scans of 202 patients diagnosed with the COVID-19, and try to develop a rapid, accurate and automatic tool for severity screening follow-up therapeutic treatment.MethodsA total of 729 2D axial plan slices with 246 severe cases and 483 non-severe cases were employed in this study. By taking the advantages of the pre-trained deep neural network, four pre-trained off-the-shelf deep models (Inception-V3, ResNet-50, ResNet-101, DenseNet-201) were exploited to extract the features from these CT scans. These features are then fed to multiple classifiers (linear discriminant, linear SVM, cubic SVM, KNN and Adaboost decision tree) to identify the severe and non-severe COVID-19 cases. Three validation strategies (holdout validation, tenfold cross-validation and leave-one-out) are employed to validate the feasibility of proposed pipelines.Results and conclusionThe experimental results demonstrate that classification of the features from pre-trained deep models shows the promising application in COVID-19 severity screening, whereas the DenseNet-201 with cubic SVM model achieved the best performance. Specifically, it achieved the highest severity classification accuracy of 95.20% and 95.34% for tenfold cross-validation and leave-one-out, respectively. The established pipeline was able to achieve a rapid and accurate identification of the severity of COVID-19. This may assist the physicians to make more efficient and reliable decisions.

Highlights

  • Chest CT is used for the assessment of the severity of patients infected with novel coronavirus 2019 (COVID-19)

  • The reverse transcription polymerase chain reaction (RT-PCR) could be used for identification of COVID-19, but it is difficult to identify the severity of COVID-19 patients, to predict whether the patient should be transferred to ICU or would need ventilators soon

  • Since the outbreak of COVID-19, the nucleic acid testing is treated as the ground truth to identify the present of the virus

Read more

Summary

Introduction

Chest CT is used for the assessment of the severity of patients infected with novel coronavirus 2019 (COVID-19). Since December 2019, the outbreak of a new coronavirus, named novel coronavirus 2019 (COVID-19), has rapidly spread across China and other countries across the globe [1,2,3,4]. The reverse transcription polymerase chain reaction (RT-PCR) could be used for identification of COVID-19, but it is difficult to identify the severity of COVID-19 patients, to predict whether the patient should be transferred to ICU or would need ventilators soon. These factors prolong the time to control the spread of COVID-19 and increase the recovery time of patients

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.